Crossmark Global Holdings’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.55M Buy
106,185
+21,270
+25% +$263K 0.02% 499
2026
Q2
$914K Sell
84,915
-48
-0.1% -$607 0.01% 654
2026
Q1
$1.27M Buy
84,963
+32,487
+62% +$475K 0.02% 535
2025
Q4
$700K Buy
52,476
+1,680
+3% +$24.5K 0.01% 724
2025
Q3
$800K Buy
50,796
+2
+0% +$33 0.01% 701
2025
Q2
$764K Buy
50,794
+26,374
+108% +$385K 0.01% 709
2025
Q1
$367K Buy
24,420
+5,829
+31% +$86.2K 0.01% 994
2024
Q4
$268K Buy
18,591
+1,799
+11% +$32.1K ﹤0.01% 1087
2024
Q3
$328K Buy
+16,792
New +$304K 0.01% 1041

Other funds holding HCM

Crossmark Global Holdings's HCM Position: Q3 2026 in Review

Crossmark Global Holdings increased its HUTCHMED (HCM) stake by 25% in Q3 2026, buying an estimated $263K and bringing the position to 106,185 shares worth $1.55M. The position accounts for 0.02% of the portfolio, ranked #499.

Crossmark Global Holdings first reported a position in HCM in Q3 2024 and has held it in 9 quarters since. 11 funds tracked by Wall St. Rank hold HCM as of Q3 2026.

  • Crossmark Global Holdings held 106,185 shares of HUTCHMED worth $1.55M as of Q3 2026.
  • Crossmark Global Holdings bought 21,270 HUTCHMED shares in Q3 2026, an estimated $263K.
  • HUTCHMED made up 0.02% of Crossmark Global Holdings's portfolio in Q3 2026, its #499 holding.
  • Crossmark Global Holdings first reported a position in HUTCHMED in Q3 2024 and has held it in 9 quarters since.
  • 11 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2026.

Based on Crossmark Global Holdings's 13F filing for Q3 2026, filed 21 Oct 2026.